Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort.
J Clin Med. 2023 Nov 8;12(22):6988. doi: 10.3390/jcm12226988.
J Clin Med. 2023.
PMID: 38002602
Free PMC article.
PRospective REgistry of PAtients in REfractory cardiogenic shock-The PREPARE CardShock registry.
von Lewinski D, Herold L, Stoffel C, Pätzold S, Fruhwald F, Altmanninger-Sock S, Kolesnik E, Wallner M, Rainer P, Bugger H, Verheyen N, Rohrer U, Manninger-Wünscher M, Scherr D, Renz D, Yates A, Zirlik A, Toth GG.
von Lewinski D, et al. Among authors: manninger wunscher m.
Catheter Cardiovasc Interv. 2022 Sep;100(3):319-327. doi: 10.1002/ccd.30327. Epub 2022 Jul 13.
Catheter Cardiovasc Interv. 2022.
PMID: 35830719
Free PMC article.
Item in Clipboard
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini JP, Caso V, Connolly SJ, Fox KAA, Oldgren J, Jones WS, Gorog DA, Durdil V, Viethen T, Neumann C, Mundl H, Patel MR; PACIFIC-AF Investigators.
Piccini JP, et al.
Lancet. 2022 Apr 9;399(10333):1383-1390. doi: 10.1016/S0140-6736(22)00456-1. Epub 2022 Apr 3.
Lancet. 2022.
PMID: 35385695
Clinical Trial.
Item in Clipboard
Cite
Cite